HCSC, Florida Blue to Cover Cologuard
Exact Sciences continues to expand its coverage of Cologuard as Health Care Service Corp (HCSC) and Florida Blue recently updated their medical policies to cover the noninvasive stool DNA screen…
Exact Sciences continues to expand its coverage of Cologuard as Health Care Service Corp (HCSC) and Florida Blue recently updated their medical policies to cover the noninvasive stool DNA screen…
Story provided by Polo Rocha, WisBusiness.com Madison-based EyeKor is planning an expansion of its platform after closing a $600,000 fundraising round. The company, which disclosed the news in an SEC filing,…
Cellectar Biosciences announced today it is the recipient of the second phase of a National Cancer Institute Fast-Track SBIR contract worth $2 million. According to a release, the money will be used to…
FluGen announced today it has begun a Phase I clinical trial of its universal influenza vaccine called RedeeFlu. “The initiation of this first-in-man study is an important milestone achieved through…
Exact Sciences announced this week that Cologuard could be included in the 2017 Healthcare Effectiveness Data and Information Set (HEDIS) quality measures for colorectal cancer screening following a proposal from the…
SHINE Medical Technologies announced today that is has entered into a strategic agreement with the largest Chinese producer and distributor of radio-pharmaceuticals, HTA, to help with the supply of molybdenum (moly-99). “HTA…
Exact Sciences is now an in-network provider of Cologuard with Anthem Blue Cross and Blue Shield in five additional states, the organization announced Wednesday. “As Cologuard’s in-network status grows in…
The U.S. Patent and Trademark Office has awarded Cellectar Biosciences a patent that covers CLR 1603, a phospholipid ether-paclitaxel conjugate, the company announced recently. “This first issued patent under our CLR CTX…
To provide resources for developing new therapies, Cellular Dynamics International, a FUJIFILM company, announced Wednesday a partnership with The Michael J. Fox Foundation for Parkinson’s Research. “Our partnership with The…
Stemina Biomarker Discovery Inc., is rebranding its diagnostics to more accurately represent its focus on neurological disorders, the company announced recently. According to a release, NeuroPointDX, a division of Stemina,…